https://doi.org/10.4081/aiua.2025.13786
Serum ferritin, bone marrow iron and mortality rate in chronic kidney disease patients with different methods of dialysis
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 19 May 2025
Background and aim: It is well recognized that one of the most significant public health concerns is chronic kidney disease (CKD). In a cohort of incident CKD patients without dialysis, or on hemodialysis (HD), or on peritoneal dialysis (PD), the complicated interactions between bone marrow iron, serum ferritin levels, and death rates were examined.
Materials and methods: For this prospective and observational study, 288 CKD patients who were registered in three institutions between January 2022 and December 2023 were initially recruited. The final analysis comprised 200 patients, chosen based on predetermined inclusion and exclusion criteria.
Results: The median age of all patients was 65.52 ± 8.36, with 102 patients (51%) being male. Of the patients followed up, forty (20%) died. Cardiovascular events accounted for 22.5% of deaths (9 patients), and infections accounted for 70% of deaths. An elevated ferritin level (HR 1.528, 95% CI 1.239-1.885, p < 0.001) and advanced age were important risk factors for infection-related cardiovascular disease.
Conclusions: It was demonstrated that higher blood ferritin levels were substantially linked to a higher risk of death and that the most common causes of death of CKD patients in Iraq are infection-related.
Downloads
Liu BC, Lan HY, Lv LL. Renal fibrosis: mechanisms and therapies. Springer Singapore. 2019.
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-S266.
Weng CH, Lu KY, Hu CC, et al. Bone marrow pathology predicts mortality in chronic hemodialysis patients. Biomed Res Int. 2015;2015:1-6.
Erdem E, Karatas A, Ecder T. The relationship between serum ferritin levels and 5-year all-cause mortality in hemodialysis patients.Blood Purif. 2022; 51:55-61.
Ueda N, Takasawa K. Impact of inflammation on ferritin, hepcidin and the management of iron deficiency anemia in chronic kidney disease. Nutrients 2018;10:1173.
Joshila Nandhini G. A study of the etiology, contributory factors and correlation of the clinical and laboratory profiles of anemia in elderly patients presenting at a tertiary hospital in rural South India [doctoral dissertation]. Tirunelveli: Tirunelveli Medical College; 2016. https://azpdf.net/document/q7wll95d-etiology-contributorycorrelation-clinical-laboratory-profiles-patients-presenting.html.
Okpechi IG, Nthite T, Swanepoel CR. Health-related quality of life in patients on hemodialysis and peritoneal dialysis. Saudi J Kidney Dis Transpl. 2013; 24:519-26.
Zazzeroni L, Pasquinelli G, Nanni E, et al. Comparison of quality of life in patients undergoing hemodialysis and peritoneal dialysis: a systematic review and meta-analysis. Kidney Blood Press Res. 2017;42:717-27.
Park KS, Ryu GW, Jhee JH, et al. Serum ferritin predicts mortality regardless of inflammatory and nutritional status in patients starting dialysis: a prospective cohort study. Blood Purif. 2015;40:209-17.
Ogawa C, Tsuchiya K, Kanda F, et al. Low levels of serum ferritin lead to adequate hemoglobin levels and good survival in hemodialysis patients. Am J Nephrol. 2015; 40:561-70.
Fujisawa H, Nakayama M, Haruyama N, et al. Association between iron status markers and kidney outcome in patients with chronic kidney disease. Sci Rep. 2023;13:18278.
Eisenga MF, Nolte IM, van der Meer P, et al. Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease. BMC Nephrol. 2018; 19:1-8.
Kalantar-Zadeh K, Höffken B, Wünsch H, et al. Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era. Am J Kidney Dis. 1995; 26:292-9.
Fernández-Rodríguez AM, Guindeo-Casasús MC, Molero-Labarta T, et al. Diagnosis of iron deficiency in chronic renal failure. Am J Kidney Dis. 1999; 34:508-13.
Blumberg AB, Marti HRM, Graber CG. Serum ferritin and bone marrow iron in patients undergoing continuous ambulatory peritoneal dialysis. JAMA 1983;250:3317-9.
Kovesdy CP, Estrada W, Ahmadzadeh S, et al. Association of markers of iron stores with outcomes in patients with nondialysis-dependent chronic kidney disease. Clin J Am Soc Nephrol. 2009; 4:435-40.
Hasuike Y, Nonoguchi H, Tokuyama M, et al. Serum ferritin predicts prognosis in hemodialysis patients: the Nishinomiya study. Clin Exp Nephrol. 2010; 14:349-55.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.